Dinuclear platinum complexes with N,N′-bis(aminoalkyl)-1,4- diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: New insights into the mechanism of resistance

Journal of Biological Inorganic Chemistry

Volumn 9, Issue 4, 2004, Pages 414-422

  Kalayda, Ganna V ^a   Jansen, Bart A J ^a   Molenaar, Chris ^b   Wielaard, Peter ^a   Tanke, Hans J ^b   Reedijk, Jan ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cisplatin resistance; Fluorescence microscopy; Glutathione; Lysosomes

Indexed keywords

ANTHRAQUINONE DERIVATIVE; CISPLATIN; GLUTATHIONE; N,N' BIS(2 AMINOETHYL) 1,4 DIAMINOANTHRAQUINONE; N,N' BIS(4 AMINOBUT 1 YL) 1,4 DIAMINOANTHRAQUINONE; N,N, BIS(3 AMINOPROP 1 YL) 1,4 DIAMINOANTHRAQUINONE; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER RESISTANCE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSOL; ENCAPSULATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LYSOSOME; OVARY CARCINOMA; PRIORITY JOURNAL;

ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL PROLIFERATION; CISPLATIN; CYTOPLASMIC VESICLES; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUORESCENT DYES; HUMANS; LIGANDS; LYSOSOMES; MICROSCOPY, FLUORESCENCE; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 3042794126     PISSN: 09498257     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00775-004-0540-5     Document Type: Article

References (30)

1. Jansen BAJ, Wielaard P, Kalayda GV, Ferrari M, Molenaar C, Tanke HJ, Brouwer J, Reedijk J (2004) J Biol Inorg Chem 9:(accompanying paper)
2. Perez RP (1998) Eur J Cancer 34:1535-1542
3. Fuertes MA, Alonso C, Perez JM (2003) Chem Rev 103:645-662
4. Shen DW, Goldenberg S, Pastan I, Gottesman MM (2000) J Cell Physiol 183:108-116
5. Godwin AK, Meister A, Odwyer PJ, Huang CS, Hamilton TC, Anderson ME (1992) Proc Natl Acad Sci USA 89:3070-3074
6. Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS (1988) Science 241:1813-1815
7. Zhen WP, Link CJ, O'Connor PM, Reed E, Parker R, Howell SB, Bohr VA (1992) Mol Cell Biol 12:3689-3698
8. Chu G (1994) J Biol Chem 269:787-790
9. Johnson SW, Shen DW, Pastan I, Gottesman MM, Hamilton TC (1996) Exp Cell Res 226:133-139
10. Chaney SG, Sancar A (1996) J Natl Cancer Inst 88:1346-1360
11. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) Cell 74:957-967
12. Moorehead RA, Singh G (2000) Biochem Pharmacol 59:337-345
13. Olivero OA, Semino C, Kassim A, Lopezlarraza DM, Poirier MC (1995) Mutat Res Lett 346:221-230
14. Molenaar C, Teuben JM, Heetebrij RJ, Tanke HJ, Reedijk J (2000) J Biol Inorg Chem 5:655-665
15. Watt GW, Cude WA (1968) Inorg Chem 7:335-338
16. Racoosin EL, Swanson JA (1993) J Cell Biol 121:1011-1020
17. Kim JH, Lingwood CA, Williams DB, Furuya W, Manolson MF, Grinstein S (1996) J Cell Biol 134:1387-1399
18. Kelland LR, Barnard CFJ, Mellish KJ, Jones M, Goddard PM, Valenti M, Bryant A, Murrer BA, Harrap KR (1994) Cancer Res 54:5618-5622
19. Perez JM, Kelland LR, Montero EI, Boxall FE, Fuertes MA, Alonso C, Navarro-Ranninger C (2003) Mol Pharmacol 63:933-944
20. Perez JM, Montero EI, Quiroga AG, Fuertes MA, Alonso C, Navarro-Ranninger C (2001) Met-Based Drugs 8:29-37
21. Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR (1991) Br J Cancer 64:215-220
22. Mulder GJ, Ouwerkerk-Mahadevan S (1997) Chem-Biol Interact 105:17-34
23. Jansen BAJ, Brouwer J, Reedijk J (2002) J Inorg Biochem 89:197-202
24. Goto S, Yoshida K, Morikawa T, Urata Y, Suzuki K, Kondo T (1995) Cancer Res 55:4297-4301
25. Timmer-Bosscha H, Mulder NH, de Vries EGE (1992) Br J Cancer 66:227-238
26. Oehlsen ME, Qu Y, Farrell N (2003) Inorg Chem 42:5498-5506
27. Aggarwal SK (1993) J Histochem Cytochem 41:1053-1073
28. Litterst CL (1984) Agents Actions 15:520-524
29. Bour-Dill C, Gramain MP, Merlin JL, Marchal S, Guillemin F (2000) Cytometry 39:16-25
30. Edwards PG, Kendall MD, Morris IW (1991) Scanning Microsc 5:797-810